SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 101.52 |
| Enterprise Value ($M) | 95.34 |
| Book Value ($M) | -18.99 |
| Book Value / Share | -1.76 |
| Price / Book | -5.35 |
| NCAV ($M) | -26.73 |
| NCAV / Share | -2.48 |
| Price / NCAV | -3.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -6.63 |
| Return on Assets (ROA) | -1.73 |
| Return on Equity (ROE) | -4.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.40 |
| Current Ratio | 3.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 30.65 |
| Assets | 38.39 |
| Liabilities | 57.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Actyus Private Equity SGIIC, S.A. | |||
| 13D/A | Gkcc, Llc | 38.70 | 159.90 | |
| 13D/A | Clal Biotechnology Industries Ltd. | 4.68 | -19.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,916 | 80,468 | 21.02 | |
| 27,460 | 144,507 | 19.00 | |
| 38,655 | 136,194 | 28.38 | |
| 14,324 | 103,713 | 13.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DYAI – Dyadic International, Inc. | EDSA – Edesa Biotech, Inc. |
| ELDN – Eledon Pharmaceuticals, Inc. | ELUT – Elutia Inc. |
| ENLV – Enlivex Therapeutics Ltd. |
Financial data and stock pages provided by
Fintel.io